These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14732319)

  • 1. The effects of rifampicin and fluoroquinolones on tubercle bacilli within human macrophages.
    Duman N; Cevikbaş A; Johansson C
    Int J Antimicrob Agents; 2004 Jan; 23(1):84-7. PubMed ID: 14732319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages.
    Rastogi N; Labrousse V; Goh KS
    Curr Microbiol; 1996 Sep; 33(3):167-75. PubMed ID: 8672093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular growth and drug susceptibility of Mycobacterium tuberculosis in macrophages.
    Chanwong S; Maneekarn N; Makonkawkeyoon L; Makonkawkeyoon S
    Tuberculosis (Edinb); 2007 Mar; 87(2):130-3. PubMed ID: 16860611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
    Bhusal Y; Shiohira CM; Yamane N
    Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of Mycobacterium kansasii to the difluorinated quinolone sparfloxacin using a broth microdilution and macrodilution MIC system.
    Royo P; Martín-Casabona N; Martínez E; Andonegui M
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):349-53. PubMed ID: 10206507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
    Coban AY; Bilgin K; Uzun M; Durupinar B
    Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro investigation of the bioactivities of ciprofloxacin and the new fluoroquinolone agents clinafloxacin (CI-960) and PD 131628 against Mycobacterium tuberculosis in human macrophages.
    Van Rensburg CE; Jooné GK; Anderson R
    Chemotherapy; 1995; 41(4):234-8. PubMed ID: 7555202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal action of gatifloxacin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.
    Paramasivan CN; Sulochana S; Kubendiran G; Venkatesan P; Mitchison DA
    Antimicrob Agents Chemother; 2005 Feb; 49(2):627-31. PubMed ID: 15673743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages.
    Crowle AJ; Elkins N; May MH
    Am Rev Respir Dis; 1988 May; 137(5):1141-6. PubMed ID: 3143278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro and intracellular activity of rifabutin on drug-susceptible and multiple drug-resistant (MDR) tubercle bacilli.
    Luna-Herrera J; Reddy MV; Gangadharam PR
    J Antimicrob Chemother; 1995 Aug; 36(2):355-63. PubMed ID: 8522465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium tuberculosis.
    Fabry W; Schmid EN; Ansorg R
    Zentralbl Bakteriol; 1995 Oct; 282(4):394-401. PubMed ID: 9810662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivities of ciprofloxacin-resistant Mycobacterium tuberculosis clinical isolates to fluoroquinolones: role of mutant DNA gyrase subunits in drug resistance.
    Suzuki Y; Nakajima C; Tamaru A; Kim H; Matsuba T; Saito H
    Int J Antimicrob Agents; 2012 May; 39(5):435-9. PubMed ID: 22421328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of the new quinolone lomefloxacin against Mycobacterium tuberculosis.
    Piersimoni C; Morbiducci V; Bornigia S; De Sio G; Scalise G
    Am Rev Respir Dis; 1992 Dec; 146(6):1445-7. PubMed ID: 1333738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein.
    Hartkoorn RC; Chandler B; Owen A; Ward SA; Bertel Squire S; Back DJ; Khoo SH
    Tuberculosis (Edinb); 2007 May; 87(3):248-55. PubMed ID: 17258938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Spectrum of Mutations in Genes Associated with Resistance to Rifampicin, Isoniazid, and Fluoroquinolones in the Clinical Strains of M. tuberculosis Reflects the Transmissibility of Mutant Clones].
    Ergeshov A; Andreevskaya SN; Larionova EE; Smirnova TG; Chernousova LN
    Mol Biol (Mosk); 2017; 51(4):595-602. PubMed ID: 28900077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of fluoroquinolones against Mycobacterium tuberculosis.
    Sulochana S; Rahman F; Paramasivan CN
    J Chemother; 2005 Apr; 17(2):169-73. PubMed ID: 15920901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of activities of rifapentine and rifampin against Mycobacterium tuberculosis residing in human macrophages.
    Mor N; Simon B; Mezo N; Heifets L
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2073-7. PubMed ID: 8540718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic activities of clarithromycin and pyrazinamide against Mycobacterium tuberculosis in human macrophages.
    Mor N; Esfandiari A
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2035-6. PubMed ID: 9303411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of RBx 7644 and RBx 8700, new investigational oxazolidinones, against Mycobacterium tuberculosis infected murine macrophages.
    Sood R; Rao M; Singhal S; Rattan A
    Int J Antimicrob Agents; 2005 Jun; 25(6):464-8. PubMed ID: 15885988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of 16 antimicrobial agents against drug-resistant strains of Mycobacterium tuberculosis.
    Fattorini L; Iona E; Ricci ML; Thoresen OF; Orrù G; Oggioni MR; Tortoli E; Piersimoni C; Chiaradonna P; Tronci M; Pozzi G; Orefici G
    Microb Drug Resist; 1999; 5(4):265-70. PubMed ID: 10647084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.